SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-025481
Filing Date
2024-05-10
Accepted
2024-05-10 16:35:36
Documents
77
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ef20026287_10q.htm   iXBRL 10-Q 1159892
2 10.1 ef20026287_ex10-1.htm EX-10.1 9968
3 EXHIBIT 31.1 ef20026287_ex31-1.htm EX-31.1 10661
4 EXHIBIT 31.2 ef20026287_ex31-2.htm EX-31.2 10582
5 EXHIBIT 32.1 ef20026287_ex32-1.htm EX-32.1 7959
  Complete submission text file 0001140361-24-025481.txt   6580700

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ocup-20240331.xsd EX-101.SCH 63943
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocup-20240331_cal.xml EX-101.CAL 34232
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocup-20240331_def.xml EX-101.DEF 285009
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocup-20240331_lab.xml EX-101.LAB 674896
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocup-20240331_pre.xml EX-101.PRE 425483
81 EXTRACTED XBRL INSTANCE DOCUMENT ef20026287_10q_htm.xml XML 974522
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 24935532
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)